Candel Therapeutics Inc.

NASDAQ: CADL
Share price (12/20/24): $8.75
Market cap (12/20/24): $284 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

CVI Investments, Inc.

Aguilar Laura K., Aguilar-Cordova Estuardo

Aguilar Laura K., Aguilar-Cordova Estuardo

Tyagarajan Seshu

News Filter

Announces $80 Million Proposed Public Offering

Announces CAN-2409 Achieved Primary Endpoint in Phase 3 Prostate Cancer Trial, Showing Significantly Improved Disease-Free Survival

Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Showcases Innovative Cancer Therapy Candidates at 16th Annual International Oncolytic Virus Conference

Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Proxies Filter

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC